“Based on the exam, I am fairly sure
that you have Parkinson’s. I can’t be 100 percent sure, as there is no test to
confirm the diagnosis. There are a variety of symptoms you could experience,
and no way to know how quickly it will progress. But no need to overreact — there are
far worse things to have. Let’s meet again in three to six months.”
Often
times, when I meet another person with Parkinson’s, we swap our “d-day” (day of
diagnosis) story. And they usually sound something like mine: after
experiencing a myriad of symptoms (dizziness, stiffness, fatigue), we go from
doctor to doctor seeking answers, until one day, one of those doctors says the
words above. We leave the office not knowing much about our disease or how to
manage it. That’s what happened to me.
As
a newly-diagnosed person with Parkinson’s, life seemed daunting. But eight years later, as an informed patient
advocate, I am working with researchers on a three-year site clinical research
study (funded by PCORI with $1.5 million) investigating how palliative care can
make life better for patients and caregivers.
Here’s
how it happened and why it matters to research.
Shared Concern and Shared Passion for Palliative Care
Luckily,
soon after my diagnosis, I was referred to movement disorder specialist Benzi
Kluger, M.D., M.S. He eased many of my worries and helped me better manage my
disease.
After
getting to know each other better, Benzi and I discussed our shared frustration
about Parkinson’s care. I found out that the “d-day” stories aren’t just
frustrating for patients, they are also concerning for doctors who care for
people with Parkinson’s.
Over time, as we discussed these challenges, some
plans started to take shape.
First, Benzi had
an idea for improving palliative care for people with moderate and advanced
Parkinson’s. In this plan, a team — a doctor, nurse, social worker and chaplain — would provide
care, planning and counseling services to people with Parkinson’s and care
partners before end-stage disease. The team would help navigate decisions
surrounding end-stage care, helping to ease angst and heartache.
Second, in addition to providing feedback on Benzi’s
plan, I put together another one for the earlier stages of Parkinson’s — a plan to improve the “d-day” experience so that
patients and care partners could take ownership from the day of diagnosis
onward.
Together, we sought to better support those living
with Parkinson’s, at all stages.
Working Together
At
around the same time, through my work as a trained Research Advocate with the
Parkinson’s Disease Foundation, I heard of opportunities to apply for research
funding from the Patient Centered Outcome Research Institute (PCORI).
After speaking to Benzi about this news,
he put together a proposal (which I reviewed) asking for funding for the first
national Parkinson’s palliative care clinical study.
A few months later, it was approved for
$1.5 million! Now, we are working on a three year research study to understand
how palliative care might improve quality of life for patients and care
partners. Not only that, we are involved in other initiatives surrounding
palliative care in Parkinson’s. For example, Benzi organized the first
international PDF conference on palliative care in Parkinson’s, where I
presented my insights in front of leading scientists. I’m happy to say those
scientists not only listened to my
insights as a patient, they also heard
them and used them to move ideas forward for improving care.
Lessons
learned
What’s the moral of the story? As
patients, we may not realize that we have the opportunity to provide meaningful
input to researchers. But we do.
In
fact, soon after my own diagnosis, both Benzi and the team at the Parkinson’s
Disease Foundation told me something —
that as a person living with PD, I was an important member of the Parkinson’s
research community.
I
wasn’t sure what this meant at first. But now I do.
And I would go a step further. I would
say that we as patients not only have the opportunity to advise researchers, we
have an obligation to do so. Researchers need to be sure they are searching for
answers to the right questions. In order to do that, they need to understand
what is important to us, the patients.
No matter how astute they are,
researchers (in most cases) don’t know what it is like to live with
Parkinson’s. I don’t have Benzi’s expertise and he doesn’t have mine.
But together we have both. If we are ever
going to improve lives and end Parkinson’s, from diagnosis forward, we need
scientists and patients on the same team.